Abstract
ABSTRACT. To identify evidence of essential fatty acid deficiency, we screened 64 patients with cystic fibrosis by analyzing total lipid extracts from plasma. Forty-three had an abnormal linoleate (18:2) level (less than 26%). Thirteen deficient patients (aged 10-24 yr) ingested for 1 yr 7% of their total calories as linoleate derived from a daily supplement of Microlipid. Five deficient patients (aged 10-37 yr) served as controls. Plasma and erythrocyte fatty acid composition were monitored by gas chromatography of total lipid extracts seven times during the twelve month period. Prostaglandins E2 and F2α and their 15 keto 13, 14 dihydrometabolite, 6-keto F1α, and thromboxane B2 were measured by radioimmunoassay. Sweat tests, oxygen saturation, growth indices, clinical severity scores, compliance, and possible side effects from taking Microlipid were followed. Results showed that oral supplementation with Microlipid can significantly increase plasma and erythrocytes %18:2. One compliant patient died during the study and had normal tissue 18:2 levels. Nine of 13 patients gained more weight while taking Microlipid than in the previous year. No significant changes in sweat electrolytes, clinical scores, or oxygen saturation were found during the study year. Prostaglandin metabolites prostaglandin E2 showed an upward trend in supplemented patients, compared to controls. Prostaglandin F2α remained unchanged over 1 yr but showed a trend significantly downward over the final 6 months in supplemented patients. We conclude that linoleate deficiency can be corrected with daily Microlipid supplements and that correction may alter prostaglandin metabolism
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mischler, E., Parrell, S., Farrell, P. et al. Correction of Linoleic Acid Deficiency in Cystic Fibrosis. Pediatr Res 20, 36–41 (1986). https://doi.org/10.1203/00006450-198601000-00010
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1203/00006450-198601000-00010
This article is cited by
-
Role for animal models in understanding essential fatty acid deficiency in cystic fibrosis
Cellular and Molecular Life Sciences (2021)
-
Elevated plasma levels of F2α isoprostane in cystic fibrosis
Lipids (1999)
-
Serum fatty acid profiles in cystic fibrosis patients and their parents
Lipids (1994)
-
Relationships between essential fatty acid levels, pulmonary function and fat absorption in pre-adolescent cystic fibrosis children with good clinical scores
European Journal of Pediatrics (1989)
-
Absorption of safflower oil and structured lipid preparations in patients with cystic fibrosis
Lipids (1987)